Sebastian Schwind

Comprehensive Cancer Center Mainfranken — Germany

Medicine · Health Sciences

39h-index8.0kcitations215works9.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(147), Hematopoietic Stem Cell Transplantation(47), Acute Lymphoblastic Leukemia research(40), Myeloproliferative Neoplasms: Diagnosis and Treatment(36), MicroRNA in disease regulation(33)

Publications214 total

The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation
Bone Marrow Transplantation·2025Open Access
Impact of cellular composition and T‐cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (<scp>CAR</scp>) T‐cells
Transfusion·2025· 2 citedOpen Access
Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation
Blood Cancer Journal·2025Open Access
Impact of Evolving <scp>WHO</scp> and <scp>ICC</scp> Classifications on Prognosis and Outcomes in <scp>AML</scp> Patients Undergoing Allogeneic Stem Cell Transplantation
American Journal of Hematology·2025Open Access
CT-Based Muscle Quality and Visceral Obesity Prior to Allogeneic Hematopoietic Stem Cell Transplantation Is of Prognostic Relevance in Patients with Acute Myeloid Leukemia
Blood·2024
Measurable Residual Disease Detection of <i>IDH1</i> or <i>IDH2</i> Mutations Post but Not Prior to Allogeneic Hematopoietic Stem Cell Transplantation Show High Prognostic Relevance in Patients with Acute Myeloid Leukemia
Blood·2024· 3 cited
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study
Haematologica·2024· 5 citedOpen Access
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma
Nature Cancer·2024· 46 cited
Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation
IJC Heart & Vasculature·2024· 1 citedOpen Access
Quantifying <i>NPM1</i> MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?
HemaSphere·2024· 3 citedOpen Access
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma
Leukemia·2024· 51 citedOpen Access
Die Testamentsvollstreckung nach deutschem Recht
Journal für Erbrecht und Vermögensnachfolge·2024
Apheresis for Production of Chimeric Antigen Receptor (CAR) T Cells in Patients with Multiple Myeloma - Clinical Factors, Cell Composition and T Cell Senescence
Blood·2023· 1 cited
Impact of Typical and Atypical Complex Karyotype Subgroups on Outcome of AML Patients Undergoing Allogeneic Stem Cell Transplantation
Blood·2023Open Access
A Novel and Cost-Efficient Measurable Residual Disease (MRD) Detection Assay Using a Single Molecule Molecular Inversion Probe-Based Next Generation Sequencing (NGS) Assay Predicts Overall Survival in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
Blood·2023Open Access
Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation
Leukemia·2023· 9 citedOpen Access
MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance
Cancers·2023· 3 citedOpen Access
Steady‐state versus chemotherapy‐based hematopoietic cell mobilization after <scp>anti‐CD38</scp>‐based induction therapy in newly diagnosed multiple myeloma
Transfusion·2023· 2 citedOpen Access
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma
Research Square (Research Square)·2023Open Access
P1415: CELLULAR DYNAMICS IN RESPONDERS AND NON-RESPONDERS AFTER THE TREATMENT OF PATIENTS WITH AGGRESSIVE B-ZELL LYMPHOMAS WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
HemaSphere·2023Open Access
page 1 of 11Next →

Frequent Co-authors

Guido Marcucci(34), Clara D. Bloomfield(30), Krzysztof Mrózek(25), Heiko Becker(25), Michael A. Caligiuri(24), Susan P. Whitman(23), Klaus H. Metzeler(21), Jonathan E. Kolitz(21), Maria R. Baer(19), Bayard L. Powell(18), Andrew J. Carroll(18), Kati Maharry(17), Michael D. Radmacher(16), Richard A. Larson(16), Yue-Zhong Wu(15), Thomas H. Carter(15), Deedra Nicolet(15), Jessica Kohlschmidt(14), Ramiro Garzon(12), Meir Wetzler(12)